AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments

After missing the boat for emergency use of COVID-19 vaccines, AstraZeneca has finally pulled the plug on efforts to sell its shot in the U.S. 

AstraZeneca has decided to withdraw its application for COVID vaccine Vaxzevria with the FDA, CEO Pascal Soriot told reporters during a press briefing Thursday. The U.S. market is already well supplied, and the demand for vaccines is declining, Soriot said.